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Original Article
Short-term stimulation with interleukin (IL)-4 enhances
purified protein derivative-induced production of an
eosinophil chemotactic Iymphokine, but suppresses
IL-5 production
Takehiko Nishiyama, Taishi Hata, Hiroki Okada and Mitsuomi Hiroshima
Department of Immunology and Immunopathology, Kagawa Medical School, Kagawa, Japan
ABSTRACT
The effect of interleukin (IL)-4 on eosinophil
chemotactic Iymphokine (ECL) production from peri-
pheral blood mononuclear cells (PBMC) stimulated
with purified protein derivative (PPD) was examined.
The PBMC stimulated with PPD in the absence of IL-4
failed to produce evident ECL. However, PPD-induced
eosinophil chemotactic activity (ECA) production was
markedly enhanced in a dose-dependent manner by
pretreatment of PBMC with IL-4. The most potent
enhancement was induced by IL-4 at a concentration
of 30 U in tuberculin-sensitive PBMC. Short-term
pretreatment (30 min to 3 h) was sufficient for the
enhancement, whereas longer-term treatment was less
effective. Eosinophil chemotactic lymphokine was
found to be a CD4+ T cell-derived factor with an
isoelectric point of approximately pH 7.0 and without
heparin affinity, unlike chemokines such as RANTES
and eotaxin. The effect of IL-4 on the production of
other cytokines, such as interferon (IFN)-y, IL-5,
RANTES (regulated on activation, normal T expressed
and secreted), and granulocyte-macrophage colony
stimulating factor (GM-CSF) was also examined.
Peripheral blood mononuclear cells produced all these
cytokines when they were treated with PPD, even in the
absence of IL-4. When PBMC were pretreated with
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IL-4, interestingly not only IFNI' but also IL-5 pro-
duction was suppressed by pretreatment with IL-4,
although ECL production was enhanced by the pre-
treatment. In the case of RANTES and GM-CSF,
significant amounts of these cytokines were produced,
even without antigenic stimulation, and IL-4 pre-
treatment did not result in an enhancement of their
production. It is thus suggested that IL-4, existing in
allergic lesions, plays a crucial role in eosinophil
accumulation mediated by the T cell-derived ECL.
Key words: eosinophil chemotactic Iymphokine,
granulocyte-macrophage colony stimulating factor,
interferon-v, interleukin-4, interleukin-5, RANTES.
INTRODUCTION
Numerous studies have shown that interleukin (IL)-4
mediates T cell differentiation from ThO cells to Th2
cells capable of producing IL-4 and IL-5. 1 Interleukin-4
also acts on various cells, such as B cells, mast cells, T
cells and mccrophoqes.? Human B cells differentiate to
IgG 4 and IgE-producing cells when they are cultured in
the presence of IL-4.3 Therefore, IL-4 has been believed
to be one of the key factors in the pathogenesis of
allergic inflammation. Interleukin-4 is produced not
only by T cells but also by basophils/mast cells and
eosinophilsv? and is detected in allergic inflammatory
sites.s-s Interleukin-4 in the allergic site is expected to
playa crucial role in the progress of the allergic inflam-
mation. Although it is likely that the effect of IL-4
stimulation at the inflammation sites is limited in the
early stages of allergic inflammation, little is known
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about the difference between short- and long-term
stimulation with Il-4.
It is generally accepted that eosinophils are crucial
cells in allergic inflammation. It has been shown that Il-5
produced from Th2 cells is the factor involved in eosino-
phil accumulation at the inflammation site.? There is no
doubt that Il-5 is an essential factor for the differentiation
and activation of eosinophils.? Although there is a
controversial report showing that Il-5 has eosinophil
chemotactic activity (ECA),lO it has been shown that
human Il-5 fails to exhibit evident ECA in eosinophils
from healthy individuals. 11,12 We have previously shown
that an eosinophil chemotactic Iymphokine (ECl) is
produced by Schistosoma mansoni- or tuberculin-
sensitive T cells stimulated with mitogen or purified pro-
tein derivative (PPD).13,14 The T cell-derived ECl has been
shown to differ to that of Il-5 and chemokines, such as
RANTES (regulated on activation, normal T expressed
and secreted) and eotaxin. 1S,16 Although it remains to be
clarified which eosinophil chemoattractant acts as a
natural mediator for eosinophil accumulation in allergic
lesions, the mediator must be produced in the sites before
eosinophil infiltration. It is therefore important to clarify
whether short-term stimulation with Il-4 enhances ECl
production from T cells more so than do the other
identified cytokines.
METHODS
Cell culture
Heparinized peripheral blood was obtained by a venous
puncture from tuberculin-sensitive volunteers without a
history of allergic diseases. Peripheral blood mononuclear
cells were purified by centrifugation on a Hypaque column
(density 1.077; Sigma Chemical Co., St louis, MO, USA)
followed by dextran sedimentation. The cells (3-5 X 1061
ml) were suspended in 5% fetal bovine serum (FBS)-
containing RPMI-1640 solution and were pretreated with
various doses of recombinant human Il-4 (Genzyme
Corp., Cambridge, MA, USA) for various periods at 37°C
in an incubator containing 5% CO2. After washing with
fresh RPMI-1640 solution, cells were further cultured in
the presence of 5 J..lg/ml PPD for 48-72 h. The culture
supernatants were used for further experiments.
In some experiments, CD4 + and CD8+ T cells were
enriched by a magnetic activated cell sorting system
using anti-CD4 or anti-CD8 monoclonal antibodies
(mAbs; Dynal AS, Oslo, Norway) to ascertain the source
of ECl, according to the manufacturer's instructions. The
CD4- and CD8-rich fractions consisted of more than
99% CD4 + and CD8+ cells, respectively.
Isoelectric electrophoresis
Isoelectric electrophoresis was performed according to a
previously described method with a Rotofor system (Bio-
Rad laboratories, Richmond, CA, USA) using carrier
ampholytes (Bio-lyte 3/10; Bio-Rad).ls In short, culture
supernatant that had been dialyzed against 1% glycine
was applied to the system. After isoelectric electro-
phoresis, 20 fractions were collected, dialyzed against
phosphate buffered saline (PBS; pH 7.4) and were used
in the present experiments.
Chemotaxis
Peripheral blood leukocytes were obtained from hep-
arinized venous blood from healthy donors. Normodense
eosinophils were separated by immunomagnetic beads
using CD 16 mAb (Dynal AS) followed by centrifugation
on a discontinuous density Percoll column (66, 71 and
78%; Pharmacia, Uppsala, Sweden). The purity of the
eosinophils was more than 98% and the viability was
more than 95%.
Chemotaxis was assessed by a modification of a
method previously described using a 48-well chemotaxis
chamber with a 5 urn pore sized polyvinylpyrolidone-free
nucleopore filter. 1? After the incubation of eosinophils
(0.5-1 X 106 /rnl, at 3JOC for 90 min, the cells that
migrated through the filter were fixed, stained with Diff-
Quick (Midori Juji, Osaka, Japan) and were counted on
5 high-power fields (h.p.f.; 40 X 10) using a calibrated
graticule. The ECA was expressed as the mean number
( ± SEM) of migrating cells/5 h.p.f. in triplicate.
In some experiments, the effects of antibodies against
Il-5 (Genzyme Corp.), GM-CSF (Genzyme Corp.) and
rabbit anti-human RANTES antibody (PharMingen, San
Diego, CA, USA) on the ECA of PPD-induced ECl from
Il-4-pretreated PBMC were assessed. In brief, the ECl
was incubated with or without the antibody for 1 h at
room temperature and was then assessed for eosinophil
chemotaxis.
Enzyme-linked immunosorbent assay
Cytokine-specific enzyme-linked immunosorbent assays
(ELISA) were used to quantify IFN-y, Il-5, RANTES and
GM-CSF in the culture supernatants according to the
manufacturer's instructions (R & D System, Minneapolis,
MN, USA). In short, assay diluent (50 Ill) and standard or
samples (200 Ill) were poured into each well of a 96-
well plate and were incubated for 2.5 h at room
temperature. After washing, 200 III conjugate was
poured into the wells and was incubated for 2.5 h. The
plates were washed again and the substrate was added.
The plates were then incubated at room temperature to
the desired extinction and the reaction was stopped with
50 III stop solution. The plates were read at 450 nm by
an ELISA reader. This ELISA method consistently detected
cytokine concentrations above 3 pg/ml for IFN-y, Il-5,
and GM-CSF or 5 pg/ml for RANTES and did not cross-
react with other cytokines.
RESULTS
Enhancement of Eel production by
pretreatment with Il-4
After pretreatment of PBMC with Il-4 (30 U) for various
periods (30 min to 48 h), the PBMC were stimulated with
5 uq/rnl, PPD and the ECA values of the supernatants were
assessed. The results are shown in Fig. 1. Little or no ECl
was produced by PBMC without antigen stimulation. No
evident ECl was produced when PPD-stimulated PBMC
were cultured without pretreatment with Il-4. When PBMC
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were stimulated with PPD followed by pretreatment with
Il-4, they produced ECl. Interleukin-4 enhanced the ECA
in PPD-stimulated PBMC in a dose-dependent manner. The
most potent enhancement was induced by 30 U of Il-4.
Therefore, we used 30 U Il-4 for subsequent experiments.
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Fig. 2 Effect of the period of pretreatment with (e) or without
(0) interleukin (IL)-4 on purified protein derivative (PPD)-
induced eosinophil chemotactic Iymphokine production.
Peripheral blood mononuclear cells from tuberculin-sensitive
donors were stimulated with PPD, then followed by treatment
with IL-4 for various periods; the supernatants were then
assessed for eosinophil chemotactic activity (ECA). Data are the
mean ± SEM of three experiments in triplicate.
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Fig.l Dose-dependent effects of interleukin (IL)-4. Peripheral
blood mononuclear cells from tuberculin-sensitive donors were
pretreated with IL-4 at various concentrations for 3 h. The cells
were stimulated with (e) or without (0) purified protein
derivative for an additional 48 h and the supernatants were
assessed for chemotaxis. Data are the mean ± SEM of four
experiments in triplicate. ECA, eosinophil chemotactic activity.
Fig. 3 Isoelectric electrophoresis of eosinophil chemotactic
Iymphokine. The culture supernatants of peripheral blood
mononuclear cells stimulated with purified protein derivative
were fractionated on a Rotofor system. Twenty fractions were
obtained and the eosinophil chemotactic activity (ECA) of each
fraction was assessed. Representative data of three experiments
in triplicate are shown.
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The effect of the period of Il-4 pretreatment on the
enhancement of ECl production was assessed. As shown
in Fig. 2, ECl production was enhanced even by short-
term stimulation with Il-4. The greatest enhancement
was induced by pretreatment for 3 h; longer pretreatment
periods were less effective. Peripheral blood mono-
nuclear cells were therefore pretreated with 30 U Il-4 for
3 h in subsequent experiments.
Next, the isoelectric point of ECl derived from PPD-
stimulated PBMC pretreated with Il-4 was assessed. As
shown in Fig. 3, the ECA of ECl was recovered from
fractions at a pH of approximately 7. No evident ECA was
detected in other fractions. By ELISA analysis, little or no
IFN-y, Il-5, RANTES or GM-CSF were detected in the
active fractions. We also found that antibodies against Il-5,
RANTES and GM-CSF failed to suppress the ECA of the
active fractions after isoelectric electrophoresis, even when
those antibodies were used simultaneously, although each
antibody could suppress the ECA of the respective cytokine
(data not shown). Bychecker-board assay, we furtherfound
that the ECl was an eosinophil chemotactic factor with
weak chemokinetic activity (data not shown).
An experiment was performed to test whether the ECl
had an affinity with heparin. Eosinophil chemotactic
Iymphokine was recovered from the effluent of heparin-
coupled beads (156 ± 11), but we failed to detect
evident ECA in the eluate (28 ± 5), suggesting that ECl
has no or little affinity with heparin.
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Fig. 4 Effects of interleukin (IL)-4
on the production of (a) interferon
(IFN)-y and (b) IL-5. The amount of
IFN-y (a) and IL-5 (b) in peripheral
blood mononuclear cell (PBMC)
supernatant is shown. The PBMC
were stimulated with or without puri-
fied protein derivative (PPD) followed
by pretreatment with or without IL-4.
Data are the mean ± SEM of three
experiments in triplicate.
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Fig. 5 Effects of interleukin (IL-4) on
the production of (a) RANTES and
(b) granulocyte-macrophage colony
stimulating factor (GM-CSF). The
amount of RANTES (a) and GM-CSF
(b) in peripheral blood mononuclear
cell (PBMC) supernatant is shown. The
PBMC were stimulated with or without
purified protein derivative (PPD) fol-
lowed by pretreatment with or without
IL-4. Data are the mean ± SEM of
three experiments in triplicate.
The source of ECl was investigated. We found that
CD4-rich cells produced evident ECl (180 ± 8),
whereas CD8-rich cells did not (34 ± 4), suggesting that
helper T cells are the source of the ECl.
Effects of IL-4 on production of other cytokines
It was examined whether the pretreatment of PBMC with
Il-4 resulted in an enhancement of IFN-y, Il-5, RANTES
and GM-CSF production. ELISA analysis revealed that
the pretreatment of PBMC with Il-4 failed to enhance the
production of any of these cytokines. As shown in Fig.
4a,b, PBMC failed to produce evident IFN-y and Il-5
when they were cultured in the absence of the antigen.
Interleukin-4 itself failed to induce any production of
those cytokines. The production of IFN-y and Il-5 was
induced by PPD stimulation. We found that Il-4
unexpectedly suppressed not only IFN-y but also Il-5
production in PPD-stimulated PBMC. In the case of
RANTES and GM-CSF, these cytokines were produced
even without any stimulation (Fig. 5a,b). Antigen stimu-
lation resulted in an enhancement of the production of
these cytokines. However, when PBMC were pretreated
with Il-4, the production of RANTES and GM-CSF was
not enhanced.
DISCUSSION
We describe herein that short-term Il-4 treatment results in
the enhancement of ECl production from PPD-stimulated
PBMC, which were probably CD4 + T cells. We found that
the ECl produced by PPD-stimulated cells has an
isoelectric point of approximately pH 7-8, with a
molecular weight of approximately 15-30 kDa (data not
shown), and that this ECl has no or little affinity with
heparin, unlike the chemokines RANTES and eotcxin.:"
Little of the ECA of this ECl was suppressed by antibodies
against Il-5, RANTES and GM-CSF, even when the ECl
was treated with these three antibodies simultaneously.
Furthermore, the above identified cytokines were negligible
in the fraction of ECl (data not shown). It is urgently
required that ECl is identified as a novel factor and we
have fortunately achieved the molecular cloning of ECl (R
Matsumoto et 01., unpubl. obs., 1997). These results will
be published separately and show that ECl is a separate
factor from those already identified (R Matsumoto et a/.,
unpubl. obs., 1997).
We and Fukushima et a/. have found that PBMC from
donors who were sensitive to Oermatofagoides farinae
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(Of) produced ECA19,20 The factor with ECA exhibited
similar biochemical properties to those of the ECl by the
antigenic stirnulotion." Furthermore, we found that Of-
induced ECl production was also potentiated when
PBMC were pretreated with Il-4. 19 Therefore, this
suggests that the involvement of Il-4 in ECl production
induced by antigenic stimulation is a generalized
phenomenon, although further studies are required to
ascertain this.
We have reported that CD4 + T cells from patients
infected with S. mansoni produce a lymphocyte-derived
eosinophil chemotactic factor of parasite disease
(lDECF-PD), resembling ECl in its physicochemical and
biological properties, when the cells were stimulated with
1 uq/rnl, concanavalin A, although T cells from healthy
donors failed to produce lDECF-PD following stimu-
lotion.P Furthermore, we found that treatment of eosino-
phi Is with lDECF-PD suppressed phorbol miristate
acetate-induced release of eosinophil cationic protein
and that this treatment resulted in an enhancement of
CD 16 and CD35 expression by eosinophils.?' These
results suggest the biological significance of ECl,
although further studies are required to clarify whether or
not ECl is the same as lDECF-PD.
It is well known that ThO cells can be differentiated to
Th2 cells when ThO cells are cultured for long periods in
the presence of Il-4. 1-3Thus, Th2 cells produce Il-3, Il-4,
Il-6 and Il- 10. 2 In contrast, Th1 cells, which have been
differentiated by IFN-y, produce Il-2 and IFN_y.22,23 It is
therefore reasonable that PPD stimulation results in the
production of IFN-y. However, the production of Il-5 was
also unexpectedly induced by PPD in the absence of Il-4.
The PBMC failed to produce IFN-y and Il-5 without
stimulation with the antigen. These results suggest that Il-
5 is also produced from PPD-stimulated T cells in
tuberculin-sensitive donors, even in the absence of Il-4.
Indeed, this is not surprising, because murine Il-5 is
produced from PPD-stimulated T cells in mice sensitized
with bacille Calmette Guerin.24-26 It is conceivable that
IFN-y production from PPD-stimulated PBMC is strongly
suppressed when cells are pretreated with Il-4.
Unexpectedly, Il-5 production was also suppressed by
pretreatment with Il-4. It has been widely accepted that
PPD stimulation in tuberculin-sensitive donors induces
classic delayed hypersensitivity that is characterized by
mononuclear leukocyte infiltrate. From the results
described earlier, the possibility that Il-5 has another
biological function other than eosinophil chemotaxis in
the absence of Il-4 cannot be excluded. Of course, there
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is no doubt that Il-5 is a key factor in eosinophil
differentiation.
It has been accepted that RANTES and GM-CSF are
produced not only by T cells but also by various types of
cells, such as macrophages and epithelial cells.27- 3o It is
clear that significant amounts of these cytokines are
produced even without any antigenic stimulation, although
antigenic stimulation results in the enhancement of their
production.
In the present study, differences in the biological
functions of Il-4 were observed between short- and long-
term stimulation with Il-4. long-term stimulation with
Il-4 may be associated with the proliferation and
differentiation of T cells and other types of cells. 2,3 For
example, Il-4 is suggested to be associated with isotype
switching and enhanced the CD23 expression of B cells.
Therefore, long-term stimulation with Il-4 may reflect the
function of Il-4 in bone marrow for the maturation of T
and B cells. In contrast, short-term stimulation with Il-4
may reflect the functions of Il-4 in allergic inflammatory
lesions, because an ECl is thought to be produced in the
allergic sites and to playa role as a mediator of eosino-
phil infiltration.
Interleukin-4 was originally thought to be the lympho-
kine produced by T cells during antigenic stimulation. 2,31 It
was recently shown that Il-4 is also produced from mast
cells and basophils in an IgE-mediated manner.5,32
Therefore, it is suggested that such short-term stimulation
reflects the function of Il-4 in allergic lesions. From the
present experiments, the possibility that mast cell-derived
Il-4 acts on T cells to produce ECl in allergic lesions during
antigenic stimulation cannot be excluded. The time course
of the production of Il-4 and ECl in allergic lesions will be
investigated.
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